ESGE Endoscopic Management Of PUD 2026.pdf
2.7 MB
Endoscopic diagnosis and management of peptic ulcer bleeding: ESGE Guideline.
2026 Update.
❤4
Endoscopic_Approach_to_Palliation_of_Pancreatic_Cancer_2026.pdf
6.8 MB
Endoscopic Approach to Palliation of Pancreatic Cancer - 2026
❤2
RESULTS; The percentage of patients with a functional cure was significantly higher with bepirovirsen than with placebo in both the B-Well 1 trial (20% vs. 0%) and the B-Well 2 trial (19% vs. 0%). Adverse events of grade 3 or higher occurred in 16% of the patients who received bepirovirsen and in 3% of those who received placebo; the most common such event with bepirovirsen was an increase in the alanine aminotransferase (ALT) level.
PDF 👇
PDF 👇
❤2
Evaluation of Abnormal Liver Biochemical Test Results.pdf
4.2 MB
Review: Evaluation of Abnormal Liver Biochemical Test Results 2026
Diathermy in gi endoscopy.pdf
1.4 MB
Principles of diathermy relevant to gastrointestinal endoscopy
Management_of_colorectal_polyps_update_and_future_directions 2025.pdf
7.6 MB
Management of colorectal polyps: update and future directions
Underwater polypectomy.pdf
2.2 MB
Underwater endoscopy in the
diagnosis and therapy of gastrointestinal neoplasia: focus on the lower gastrointestinal tract
diagnosis and therapy of gastrointestinal neoplasia: focus on the lower gastrointestinal tract
Endoscopic anti-Reflux.pdf
1.7 MB
Endoscopic antireflux options and beyond: which patients, which techniques?
Neoplasia in IBD.pdf
1.6 MB
Management of neoplasia in inflammatory bowel disease
Practical Considerations for the Use of Semaglutide in MASH.pdf
901.6 KB
Practical Considerations for the Use of Semaglutide in MASH
AJG 2026
❤4
Optimisation of ERCP for common bie duct stone.pdf
1.1 MB
Optimisation of ERCP for common bile duct stones.
BMJ 2026